Brinker Capital Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.1M | Sell |
419,584
-26,907
| -6% | -$704K | 0.08% | 218 |
|
|
2026
Q1 | $12.5M | Sell |
446,491
-58,759
| -12% | -$1.56M | 0.11% | 169 |
|
|
2025
Q4 | $12.6M | Buy |
505,250
+32,206
| +7% | +$812K | 0.09% | 195 |
|
|
2025
Q3 | $12.1M | Sell |
473,044
-236,206
| -33% | -$5.83M | 0.09% | 188 |
|
|
2025
Q2 | $17.2M | Buy |
709,250
+40,805
| +6% | +$952K | 0.15% | 124 |
|
|
2025
Q1 | $16.9M | Buy |
668,445
+86,175
| +15% | +$2.25M | 0.17% | 114 |
|
|
2024
Q4 | $15.4M | Buy |
582,270
+29,552
| +5% | +$802K | 0.15% | 122 |
|
|
2024
Q3 | $16M | Sell |
552,718
-32,991
| -6% | -$962K | 0.16% | 127 |
|
|
2024
Q2 | $16.4M | Buy |
585,709
+27,141
| +5% | +$747K | 0.17% | 116 |
|
|
2024
Q1 | $15.5M | Buy |
558,568
+71,493
| +15% | +$1.98M | 0.17% | 126 |
|
|
2023
Q4 | $14.4M | Sell |
487,075
-101,509
| -17% | -$3.07M | 0.17% | 126 |
|
|
2023
Q3 | $19.5M | Sell |
588,584
-83,394
| -12% | -$2.95M | 0.24% | 88 |
|
|
2023
Q2 | $24.6M | Buy |
671,978
+7,003
| +1% | +$273K | 0.26% | 67 |
|
|
2023
Q1 | $27.1M | Buy |
664,975
+258,150
| +63% | +$11.1M | 0.33% | 53 |
|
|
2022
Q4 | $20.8M | Buy |
406,825
+15,873
| +4% | +$761K | 0.42% | 47 |
|
|
2022
Q3 | $17.1M | Sell |
390,952
-8,855
| -2% | -$430K | 0.35% | 59 |
|
|
2022
Q2 | $21M | Buy |
399,807
+7,289
| +2% | +$371K | 0.4% | 46 |
|
|
2022
Q1 | $20.3M | Buy |
392,518
+75,947
| +24% | +$3.94M | 0.31% | 60 |
|
|
2021
Q4 | $18.7M | Buy |
316,571
+18,878
| +6% | +$935K | 0.27% | 79 |
|
|
2021
Q3 | $11.7M | Buy |
297,693
+8,011
| +3% | +$355K | 0.19% | 112 |
|
|
2021
Q2 | $11.3M | Buy |
289,682
+44,574
| +18% | +$1.73M | 0.15% | 148 |
|
|
2021
Q1 | $8.88M | Sell |
245,108
-21,142
| -8% | -$751K | 0.13% | 165 |
|
|
2020
Q4 | $9.8M | Sell |
266,250
-166,814
| -39% | -$6.12M | 0.15% | 149 |
|
|
2020
Q3 | $15.1M | Buy |
433,064
+393,578
| +997% | +$13.8M | 0.26% | 88 |
|
|
2020
Q2 | $1.23M | Buy |
39,486
+25,994
| +193% | +$883K | 0.05% | 194 |
|
|
2020
Q1 | $418K | Buy |
13,492
+1,409
| +12% | +$48K | 0.02% | 255 |
|
|
2019
Q4 | $449K | Buy |
12,083
+1,336
| +12% | +$47.6K | 0.02% | 272 |
|
|
2019
Q3 | $366K | Buy |
10,747
+8,757
| +440% | +$318K | 0.01% | 286 |
|
|
2019
Q2 | $82K | Buy |
1,990
+885
| +80% | +$35.1K | ﹤0.01% | 522 |
|
|
2019
Q1 | $45K | Sell |
1,105
-717
| -39% | -$28.7K | ﹤0.01% | 484 |
|
|
2018
Q4 | $75K | Buy |
1,822
+8
| +0.4% | +$332 | ﹤0.01% | 361 |
|
|
2018
Q3 | $76K | Sell |
1,814
-32
| -2% | -$1.23K | ﹤0.01% | 338 |
|
|
2018
Q2 | $64K | Buy |
1,846
+553
| +43% | +$18.9K | ﹤0.01% | 354 |
|
|
2018
Q1 | $44K | Buy |
1,293
+527
| +69% | +$18.1K | ﹤0.01% | 361 |
|
|
2017
Q4 | $26K | Sell |
766
-42
| -5% | -$1.43K | ﹤0.01% | 387 |
|
|
2017
Q3 | $27K | Buy |
808
+276
| +52% | +$8.87K | ﹤0.01% | 375 |
|
|
2017
Q2 | $17K | Sell |
532
-272
| -34% | -$8.58K | ﹤0.01% | 378 |
|
|
2017
Q1 | $26K | Hold |
804
| – | – | ﹤0.01% | 340 |
|
|
2016
Q4 | $25K | Sell |
804
-228
| -22% | -$6.96K | ﹤0.01% | 335 |
|
|
2016
Q3 | $33K | Buy |
1,032
+272
| +36% | +$9.1K | ﹤0.01% | 311 |
|
|
2016
Q2 | $25K | Hold |
760
| – | – | ﹤0.01% | 316 |
|
|
2016
Q1 | $21K | Sell |
760
-422
| -36% | -$12.1K | ﹤0.01% | 326 |
|
|
2015
Q4 | $36K | Buy |
1,182
+106
| +10% | +$3.33K | ﹤0.01% | 340 |
|
|
2015
Q3 | $32K | Hold |
1,076
| – | – | ﹤0.01% | 332 |
|
|
2015
Q2 | $34K | Sell |
1,076
-672
| -38% | -$21.9K | ﹤0.01% | 320 |
|
|
2015
Q1 | $58K | Buy |
1,748
+672
| +62% | +$21.4K | ﹤0.01% | 304 |
|
|
2014
Q4 | $32K | Sell |
1,076
-5,593
| -84% | -$160K | ﹤0.01% | 316 |
|
|
2014
Q3 | $187K | Buy |
6,669
+428
| +7% | +$12K | 0.01% | 238 |
|
|
2014
Q2 | $176K | Sell |
6,241
-1,318
| -17% | -$37.6K | 0.01% | 258 |
|
|
2014
Q1 | $230K | Buy |
7,559
+6,483
| +603% | +$193K | 0.01% | 250 |
|
|
2013
Q4 | $31K | Sell |
1,076
-7,322
| -87% | -$213K | ﹤0.01% | 294 |
|
|
2013
Q3 | $229K | Buy |
8,398
+499
| +6% | +$13.6K | 0.01% | 249 |
|
|
2013
Q2 | $210K | Buy |
+7,899
| New | +$218K | 0.01% | 252 |
|
Other funds holding PFE
Brinker Capital Investments's PFE Position: Q2 2026 in Review
Brinker Capital Investments reduced its Pfizer (PFE) stake by 6% in Q2 2026, selling an estimated $704K and leaving 419,584 shares worth $10.1M. The position accounts for 0.08% of the portfolio, ranked #218.
Brinker Capital Investments first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $27.1M in Q1 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Brinker Capital Investments held 419,584 shares of Pfizer worth $10.1M as of Q2 2026.
- Brinker Capital Investments sold 26,907 Pfizer shares in Q2 2026, an estimated $704K.
- Pfizer made up 0.08% of Brinker Capital Investments's portfolio in Q2 2026, its #218 holding.
- Brinker Capital Investments first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Brinker Capital Investments's Pfizer position peaked at $27.1M in Q1 2023.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.